AVITA Medical, Inc. (RCEL): Form 8-K filed 2026-11-13
- Accepted by EDGAR
- 2026-11-13 16:33 ET
- Event date
- 2026-11-13
- Accession no.
- 0001193125-26-460809
- Original filing
- SEC EDGAR filing index
AI summary of the filing text. It can contain mistakes; the original filing is authoritative.
AVITA Medical discloses cashless warrant exercises by Perceptive and OrbiMed
AVITA Medical disclosed cashless exercises of previously issued warrants by Perceptive and OrbiMed. The Company issued 119,375 shares to Perceptive and 148,158 shares to OrbiMed on November 11, 2026, withholding additional shares to cover the exercise prices.
- Perceptive received 119,375 shares on November 11, 2026, through a cashless warrant exercise.
- OrbiMed received 148,158 shares on November 11, 2026, through a cashless warrant exercise.
- AVITA Medical withheld 30,625 shares for Perceptive's exercise price and 261,503 shares for OrbiMed's exercise price.
- The Perceptive Warrant became exercisable when the Company borrowed additional funds on November 3, 2026.
financing
Items reported
- Item 7.01: Regulation FD Disclosure
The company is making information public under Regulation FD, which requires broad public disclosure of material information shared with certain market participants. Investor presentations and press releases are common. Like Item 2.02, this information is generally "furnished" rather than "filed".
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | 8-K | rcel-20261113.htm |
The summary above was generated by AI from the filing text and checked automatically against it. Read the original documents on SEC EDGAR. How to read an 8-K.